Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum CD133-Associated Proteins Identified by Machine Learning Are Connected to Neural Development, Cancer Pathways, and 12-Month Survival in Glioblastoma.
Joyce T, Tasci E, Jagasia S, Shephard J, Chappidi S, Zhuge Y, Zhang L, Cooley Zgela T, Sproull M, Mackey M, Camphausen K, Krauze AV. Joyce T, et al. Among authors: sproull m. Cancers (Basel). 2024 Aug 1;16(15):2740. doi: 10.3390/cancers16152740. Cancers (Basel). 2024. PMID: 39123468 Free PMC article.
Antiangiogenic therapy through copper chelation.
Sproull M, Brechbiel M, Camphausen K. Sproull M, et al. Expert Opin Ther Targets. 2003 Jun;7(3):405-9. doi: 10.1517/14728222.7.3.405. Expert Opin Ther Targets. 2003. PMID: 12783576 Review.
Evaluation of copper chelation agents as anti-angiogenic therapy.
Camphausen K, Sproull M, Tantama S, Sankineni S, Scott T, Ménard C, Coleman CN, Brechbiel MW. Camphausen K, et al. Among authors: sproull m. Bioorg Med Chem. 2003 Sep 15;11(19):4287-93. doi: 10.1016/s0968-0896(03)00401-2. Bioorg Med Chem. 2003. PMID: 12951159
Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy.
Chan LW, Moses MA, Goley E, Sproull M, Muanza T, Coleman CN, Figg WD, Albert PS, Ménard C, Camphausen K. Chan LW, et al. Among authors: sproull m. J Clin Oncol. 2004 Feb 1;22(3):499-506. doi: 10.1200/JCO.2004.07.022. J Clin Oncol. 2004. PMID: 14752073 Clinical Trial.
52 results